ImmunologybioRxiv
Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice
T. Noy-Porat, A. Mechaly, Y. Levy…·R. Rosenfeld
This study identifies and characterizes neutralizing antibodies targeting the SARS-CoV-2 spike N-terminal domain, showing their protective efficacy in mice.
DOI 10.1016/j.isci.2021.102479